Covidien launches minimally invasive surgical products in Europe
11 April 2008
Covidien (NYSE: COV, BSX: COV) has announced that its Surgical
Devices business unit has launched three new surgical access products in
Europe, the VersaStep Plus 15mm, Visiport Plus with fixation and
Versaport Plus RPF 15mm with fixation.
The VersaStep Plus 15mm is an innovative bladeless laparoscopic
access system with a radially expandable sleeve that minimizes the
fascial defect and reduces the downward insertion forces associated with
normal trocar insertion. It uses the company's proprietary Proven Step
technology that is designed to enhance patient safety, save time in
surgery and reduce the likelihood of complications, including vascular
and visceral injuries.
The Visiport Plus with fixation supplies a Versaport Plus fixation
cannula, an enhanced cannula with integrated fixation ribs for excellent
port stability, and a Visiport Plus optical trocar that provides direct
visualization of tissue layers during primary port insertion and allows
a combination of controlled blunt and sharp dissection during entry.
The Versaport Plus RPF 15mm with fixation is used in advanced
laparoscopic procedures as it accommodates larger instrumentation. The
Versaport Plus RPF 15mm is also now supplied with an enhanced cannula
with integrated fixation ribs for excellent port stability.